CORT Financial Facts

Net loss and comprehensive loss: 2.59M
Loss from operations: 3.07M
See Full Income Statement

Prepaid expenses and other current assets: 1.35M
Other assets: 24K
See Full Balance Sheet

Corcept Therapeutics (CORT) Earnings

  |   Expand Research on CORT
Next EPS Date 7/31/26 *Est. EPS Growth Rate -100.0% *Last Qtr.
Average EPS % Beat Rate +17.3% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +3.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/26 Q126 N/A-$0.11 N/A N/A$183.5M = N/A N/A
2/24/26 Q425 $0.20$0.25 -$0.05$202.12M$249.52M = Details
2/18/26 Q425 N/A$0.25 N/A N/A$249.52M = N/A N/A
11/4/25 Q325 $0.16$0.13 +$0.03$207.6M$218.53M = Details
7/31/25 Q225 $0.29$0.19 +$0.10$194.4M$199.4M = Details
5/5/25 Q125 $0.17$0.15 +$0.02$157.2M$177.94M = Details
2/26/25 Q424 $0.26$0.38 -$0.12$181.89M$198.05M = Details
2/17/25 Q424 N/A$0.38 N/A N/A$198.05M = N/A N/A